Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR

Summary

Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR is a clinical trial^[1].

Key Facts

• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR is in the country of United States^[2].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's instance of is recorded as clinical trial^[3].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's start time is recorded as +2021-02-28T00:00:00Z^[4].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's end time is recorded as +2023-02-28T00:00:00Z^[5].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's main subject is recorded as kidney transplantation^[6].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's main subject is recorded as immunosuppressive drug^[7].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's number of participants is recorded as {'unit': '1', 'amount': '+80'}^[8].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's title is recorded as SIMPLE Study: A Prospective and Randomized Trial of a Simplified Immunosuppressive Protocol Utilizing Low Dose EnvarsusXR^[9].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's short name is recorded as SIMPLE^[10].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's ClinicalTrials.gov ID is recorded as NCT04773392^[12].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+85'}^[13].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's research intervention is recorded as mycophenolic acid^[14].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's research intervention is recorded as prednisone^[15].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's research intervention is recorded as basiliximab^[16].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's research intervention is recorded as anti-lymphocyte globulin^[17].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's research intervention is recorded as methylprednisolone^[18].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's research intervention is recorded as azathioprine^[19].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's research intervention is recorded as tacrolimus^[20].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's research intervention is recorded as anti-thymocyte globulin (rabbit)^[21].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's research intervention is recorded as antimetabolite^[22].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's clinical trial phase is recorded as phase IV clinical trial^[23].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's research site is recorded as University of Southern California^[24].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's research subject recruitment status is recorded as recruiting^[25].
• Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR's study type is recorded as interventional study^[26].